Skip to content
10-Q

Quarterly Report

Lazuriton Nano Biotechnology (U.S.A.) Inc.

0001640334-19-001749

← back to feed
Filed
Aug 26, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Aug 12, 2019 0 sh
Current Liabilities Q2 2019 · Jun 30, 2019 $233.19K
Current Liabilities Q2 2019 · Dec 31, 2018 $198.88K
Total Liabilities Q2 2019 · Jun 30, 2019 $233.19K
Total Liabilities Q2 2019 · Dec 31, 2018 $198.88K
Current Assets Q2 2019 · Jun 30, 2019 $1.35K
Current Assets Q2 2019 · Dec 31, 2018 $2.12K
Total Assets Q2 2019 · Jun 30, 2019 $1.35K
Total Assets Q2 2019 · Dec 31, 2018 $2.12K
Stockholders Equity Q2 2019 · Mar 31, 2018 −$134.19K
Net Income Q2 2019 · Mar 31, 2018 −$29.95K